GABAergic Sensitization of the Serotonin System in Stress-Induced Opiate Relapse
应激性阿片类药物复吸中血清素系统的 GABA 能敏化
基本信息
- 批准号:8682456
- 负责人:
- 金额:$ 23.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAnalgesicsAnimal ModelAnimalsBehavioralCellsCorticotropin-Releasing HormoneDataElectrophysiology (science)EngineeringExploratory/Developmental GrantGenesGeneticGenetic RecombinationHealthImmunohistochemistryLaboratoriesModelingMoodsMorphineMorphine DependenceMusNeurobiologyNeurohormonesNeuronsOpiate AddictionOpiatesOpioidPathway interactionsPublic HealthQuantitative AutoradiographyRecording of previous eventsRegulationRelapseReporterResistanceRewardsRodentRoleSelf AdministrationSerotoninSignal TransductionStressSwimmingSystemTamoxifenTestingViralWorkbasebiological adaptation to stressdisorder later incidence preventiondorsal raphe nucleusdrug seeking behaviorgamma-Aminobutyric Acidinnovationnovelpreferencepromoterraphe nucleireceptorrecombinasestressortool
项目摘要
DESCRIPTION (provided by applicant): Opioids are effective analgesics but also carry a high abuse liability. Even after prolonged abstinence, former opioid addicts can remain vulnerable to relapse, particularly under stressful conditions. Most of the focus on opioid addiction and relapse mechanisms have centered on traditional dopaminergic reward pathways. Fewer studies have examined the role of the serotonin (5-hydroxytryptamine; 5-HT) system in opioid addiction and relapse. Preliminary data in rodents indicate that stress interacts with opioid history to sensitize 5-HT dorsal raphe nucleus (DRN) neurons to GABAergic inhibition. More recent work identified a causal relationship between GABA signaling in the DRN and stress-induced opioid reinstatement. We hypothesize that this GABAergic sensitization results in serotonergic hypofunction and consequent dysphoric mood states which drive drug-seeking behaviors and therefore confer vulnerability to stress- induced opioid relapse. In the current application, we will employ two state-of-the-art genetic mutational strategies using the Cre-loxP system to engineer mice that are deficient in GABAA receptors selectively in the DRN or specifically in 5-HT neurons. First, we will confirm DRN- or 5-HT-specific deletion of the GABAA receptor in these mice using immunohistochemistry, electrophysiology and quantitative autoradiography. Next, we will test these mice in two complementary animal models of relapse in which a swim stress is used to reinstate previously extinguished morphine conditioned place-preference or self-administration. We predict that these mice will be protected from the GABAergic sensitization observed in the 5-HT DRN system following a stress-induced relapse model and will thus be less vulnerable to relapse in these two models. These studies will generate innovative animal models of opiate relapse resistance that will be a valuable tool to elucidate novel circuitry within the 5-HT DRN system that contribute to opiate relapse. This approach may identify novel targets for the treatment of opiate addiction and the prevention of relapse.
描述(由申请人提供):阿片类药物是有效的镇痛剂,但也有很高的滥用倾向。即使在长期禁欲之后,前阿片类药物成瘾者仍然容易复发,特别是在压力条件下。阿片类药物成瘾和复发机制的大部分焦点集中在传统的多巴胺能奖励途径。很少有研究探讨5-羟色胺(5-HT)系统在阿片类药物成瘾和复发中的作用。啮齿类动物的初步数据表明,应激与阿片类药物史相互作用,使5-HT中缝背核(DRN)神经元对GABA能抑制敏感。最近的工作确定了DRN中的GABA信号传导与应激诱导的阿片类物质恢复之间的因果关系。我们假设,这种GABA能敏化导致多巴胺能功能减退和随后的烦躁情绪状态,这些情绪状态驱动药物寻求行为,因此容易受到应激诱导的阿片类药物复发的影响。在本申请中,我们将采用两种最先进的遗传突变策略,使用Cre-loxP系统来工程化选择性地在DRN或特别是在5-HT神经元中缺乏GABAA受体的小鼠。首先,我们将确认DRN或5-HT特异性缺失的GABAA受体在这些小鼠中使用免疫组织化学,电生理学和定量放射自显影。接下来,我们将在两个互补的复发动物模型中测试这些小鼠,其中游泳应激用于恢复先前熄灭的吗啡条件性位置偏好或自我给药。我们预测,这些小鼠将受到保护,从GABA能敏化观察到的5-HT DRN系统后,应激诱导的复发模型,因此将不太容易复发,在这两个模型。这些研究将产生创新的阿片类药物复吸抗性的动物模型,这将是一个有价值的工具,以阐明新的电路内的5-HT DRN系统,有助于阿片类药物复吸。这种方法可以确定新的目标,阿片类药物成瘾的治疗和预防复发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LYNN G KIRBY其他文献
LYNN G KIRBY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LYNN G KIRBY', 18)}}的其他基金
Regulation of 5-HT circuits by CRF and GABA in opioid addiction and stress-induced relapse
CRF 和 GABA 对阿片类药物成瘾和应激性复发中 5-HT 回路的调节
- 批准号:
10556667 - 财政年份:2022
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of 5-HT circuits by CRF and GABA in opioid addiction and stress-induced relapse
CRF 和 GABA 对阿片类药物成瘾和应激性复发中 5-HT 回路的调节
- 批准号:
10306376 - 财政年份:2019
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of 5-HT circuits by CRF and GABA in opioid addiction and stress-induced relapse
CRF 和 GABA 对阿片类药物成瘾和应激性复发中 5-HT 回路的调节
- 批准号:
10529276 - 财政年份:2019
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of 5-HT circuits by CRF and GABA in opioid addiction and stress-induced relapse
CRF 和 GABA 对阿片类药物成瘾和应激性复发中 5-HT 回路的调节
- 批准号:
10058830 - 财政年份:2019
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of Serotonin Circuits in Opiate Addiction and Relapse
阿片成瘾和复发中血清素回路的调节
- 批准号:
7624672 - 财政年份:2006
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of Serotonin Circuits in Opiate Addiction and Relapse
阿片成瘾和复发中血清素回路的调节
- 批准号:
7430388 - 财政年份:2006
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of Serotonin Circuits in Opiate Addiction and Relapse
阿片成瘾和复发中血清素回路的调节
- 批准号:
7209574 - 财政年份:2006
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of Serotonin Circuits in Opiate Addiction and Relapse
阿片成瘾和复发中血清素回路的调节
- 批准号:
7294920 - 财政年份:2006
- 资助金额:
$ 23.36万 - 项目类别:
Regulation of Serotonin Circuits in Opiate Addiction and Relapse
阿片成瘾和复发中血清素回路的调节
- 批准号:
7860649 - 财政年份:2006
- 资助金额:
$ 23.36万 - 项目类别:
Neurobiology of Anxiety in 5-HT1A Receptor Knockout Mice
5-HT1A 受体敲除小鼠焦虑的神经生物学
- 批准号:
6437934 - 财政年份:2002
- 资助金额:
$ 23.36万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 23.36万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 23.36万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 23.36万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 23.36万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 23.36万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 23.36万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 23.36万 - 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 23.36万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 23.36万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 23.36万 - 项目类别: